{"id":"https://openalex.org/W3197499792","doi":null,"title":"Dynamic changes in peripheral T cell populations predict response to PD-1 immunotherapy","display_name":"Dynamic changes in peripheral T cell populations predict response to PD-1 immunotherapy","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W3197499792","mag":"3197499792"},"language":"en","primary_location":{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/b8bd73a6-8446-4c31-9309-2cddbf8044ca","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/b8bd73a6-8446-4c31-9309-2cddbf8044ca","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Valpione, S, Marais, R, Galvani, E, Mundra, P, Dhomen, N, Lorigan, P, Gremel, G, Tweedy, J, Banyard, A, Barry, J, Williams, G, Middlehurst, P & Gremel, G 2018, Dynamic changes in peripheral T cell populations predict response to PD-1 immunotherapy. in Dynamic changes in peripheral T cell populations predict response to PD-1 immunotherapy. < https://www.societymelanomaresearch.org/docs/congress/congress_abstracts_2018.pdf >","raw_type":"info:eu-repo/semantics/conferenceObject"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025502988","display_name":"Sara Valpione","orcid":"https://orcid.org/0000-0001-9641-3819","observed_orcids":["https://orcid.org/0000-0001-9641-3819"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara Valpione","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9641-3819","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059637661","display_name":"Richard Marais","orcid":"https://orcid.org/0000-0001-7484-4183","observed_orcids":["https://orcid.org/0000-0001-7484-4183"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Marais","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7484-4183","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041399505","display_name":"Elena Galvani","orcid":"https://orcid.org/0000-0002-3057-641X","observed_orcids":["https://orcid.org/0000-0002-3057-641X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Galvani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010448208","display_name":"Piyushkumar A. Mundra","orcid":"https://orcid.org/0000-0001-7769-2939","observed_orcids":["https://orcid.org/0000-0001-7769-2939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piyushkumar A. Mundra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7769-2939","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066331764","display_name":"Nathalie S. Dhomen","orcid":"https://orcid.org/0000-0003-1961-2173","observed_orcids":["https://orcid.org/0000-0003-1961-2173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathalie Dhomen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069095893","display_name":"Paul C. Lorigan","orcid":"https://orcid.org/0000-0002-8875-2164","observed_orcids":["https://orcid.org/0000-0002-8875-2164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Lorigan","raw_affiliation_strings":["Division of Cancer Sciences (L5)"],"raw_orcid":"https://orcid.org/0000-0002-8875-2164","affiliations":[{"raw_affiliation_string":"Division of Cancer Sciences (L5)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088690848","display_name":"Gabriela Gremel","orcid":"https://orcid.org/0000-0002-1330-1051","observed_orcids":["https://orcid.org/0000-0002-1330-1051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriela Gremel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006313089","display_name":"Joshua Tweedy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua Tweedy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069493161","display_name":"Antonia Banyard","orcid":"https://orcid.org/0000-0002-2430-8013","observed_orcids":["https://orcid.org/0000-0002-2430-8013"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonia Banyard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2430-8013","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000534514","display_name":"Jeff Barry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeff Barry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111622752","display_name":"Gillian Williams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gillian Williams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5068260167","display_name":"Philippa Middlehurst","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippa Middlehurst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7649999856948853},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.859000027179718},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8610000014305115},{"id":"https://openalex.org/keywords/t-cell-turnover","display_name":"T cell turnover","score":0.6399999856948853},{"id":"https://openalex.org/keywords/t-cell-receptor-beta-repertoire","display_name":"T cell receptor beta repertoire","score":0.8420000076293945},{"id":"https://openalex.org/keywords/cell-free-dna","display_name":"cell-free DNA","score":0.9409999847412109},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.7839999794960022},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.6919999718666077},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.847000002861023},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5972672700881958},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.49897313117980957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4135911762714386},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3741484582424164},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3679038882255554},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30277588963508606},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19339525699615479}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/b8bd73a6-8446-4c31-9309-2cddbf8044ca","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/b8bd73a6-8446-4c31-9309-2cddbf8044ca","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Valpione, S, Marais, R, Galvani, E, Mundra, P, Dhomen, N, Lorigan, P, Gremel, G, Tweedy, J, Banyard, A, Barry, J, Williams, G, Middlehurst, P & Gremel, G 2018, Dynamic changes in peripheral T cell populations predict response to PD-1 immunotherapy. in Dynamic changes in peripheral T cell populations predict response to PD-1 immunotherapy. < https://www.societymelanomaresearch.org/docs/congress/congress_abstracts_2018.pdf >","raw_type":"info:eu-repo/semantics/conferenceObject"},{"id":"mag:3197499792","doi":null,"is_oa":false,"landing_page_url":"https://www.research.manchester.ac.uk/portal/en/publications/dynamic-changes-in-peripheral-t-cell-populations-predict-response-to-pd1-immunotherapy(b8bd73a6-8446-4c31-9309-2cddbf8044ca).html","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3005411249","https://openalex.org/W4313706410","https://openalex.org/W2778514225","https://openalex.org/W4386143275","https://openalex.org/W2548844390","https://openalex.org/W3032453141","https://openalex.org/W7165673422","https://openalex.org/W4388895609","https://openalex.org/W4284703131","https://openalex.org/W3005429093"],"abstract_inverted_index":{"Immunotherapy":[0],"has":[1],"revolutionised":[2],"melanoma":[3,49],"treatment,":[4],"but":[5,139],"most":[6],"patients":[7,50,132,142,151],"still":[8],"die":[9],"of":[10,45,150,156,164,172],"disease.":[11],"Blood-based":[12],"biomarkers":[13],"to":[14,72,104,136],"identify":[15],"check-point":[16],"inhibitors":[17],"(CPI)":[18],"response":[19],"early":[20],"during":[21,57],"treatment":[22],"will":[23],"provide":[24],"useful":[25],"and":[26,40,56,78,110],"easily":[27],"accessible":[28],"guidance":[29],"for":[30],"clinical":[31],"decisions.":[32],"We":[33,119],"analysed":[34,111,153],"peripheral":[35],"blood":[36],"mononuclear":[37],"cells":[38],"(PBMCs)":[39],"plasma":[41],"cell-free":[42],"DNA":[43],"(cfDNA)":[44],"26":[46],"stage":[47],"IV":[48],"before":[51],"(before":[52],"the":[53,154],"1stdose,":[54],"T0)":[55],"(at":[58],"week":[59],"3,":[60],"W3)":[61],"therapy":[62,137],"with":[63,183],"1stline":[64],"CPI":[65],"(anti-PD1":[66],"or":[67],"anti-PD1":[68],"plus":[69],"anti-CTLA-4":[70],"drugs)":[71],"study":[73],"circulating":[74],"T":[75,79,107,124,157,165,179],"lymphocyte":[76],"subsets":[77],"cell":[80,108,125,158,166,180],"receptor":[81],"beta":[82],"(TCR\u03b2)":[83],"repertoire.":[84],"Responses":[85],"were":[86,117],"determined":[87],"at":[88,129],"12":[89],"weeks":[90],"(W12)":[91],"as":[92],"per":[93],"standard":[94],"practice.":[95],"In":[96,147],"PBMCs,":[97],"we":[98,152,176],"used":[99],"high":[100],"dimensional":[101],"flow":[102],"cytometry":[103],"quantify":[105],"20":[106],"subpopulations":[109],"if":[112],"their":[113],"changes":[114],"over":[115],"time":[116],"prognostic.":[118],"found":[120,177],"that":[121,178],"a":[122,148],"CD8+":[123],"subpopulation":[126],"(Teff)":[127],"expanded":[128],"W3":[130],"in":[131,141],"who":[133,143],"then":[134],"responded":[135],"(N=13),":[138],"not":[140],"progressed":[144],"(N=13)":[145],"(P<0.001).":[146],"subgroup":[149],"pattern":[155],"turnover,":[159],"which":[160],"is":[161],"also":[162],"indicative":[163],"clearance.":[167],"Assessed":[168],"indirectly":[169],"by":[170],"means":[171],"cfDNA":[173],"TCR\u03b2":[174],"sequences,":[175],"turnover":[181],"correlated":[182],"Teff":[184],"expansion":[185],"(P=0.013).":[186]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2021-09-13T00:00:00"}